Omada Health (NASDAQ:OMDA) Now Covered by Analysts at The Goldman Sachs Group

Research analysts at The Goldman Sachs Group assumed coverage on shares of Omada Health (NASDAQ:OMDA - Get Free Report) in a research note issued on Tuesday,Briefing.com Automated Import reports. The firm set a "buy" rating and a $29.00 price target on the stock. The Goldman Sachs Group's target price would suggest a potential upside of 58.47% from the stock's current price.

A number of other analysts have also recently weighed in on the stock. Canaccord Genuity Group initiated coverage on shares of Omada Health in a research note on Tuesday. They issued a "buy" rating and a $27.00 price objective for the company. Wall Street Zen upgraded shares of Omada Health to a "hold" rating in a report on Monday, June 16th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, Omada Health has an average rating of "Moderate Buy" and an average target price of $24.00.

Omada Health Trading Up 3.9%

Shares of NASDAQ OMDA opened at $18.30 on Tuesday. Omada Health has a 52 week low of $14.14 and a 52 week high of $28.40.

About Omada Health

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.